Use of sofosbuvir in combination with ribavirin with or without pegylated interferon for the treatment of patients with hepatitis C infection genotype 4

Yehia M. Al Shazly; Sherif M. Mohamed; Ossama A. Ahmed; Rasha S. Mohamed; Ahmed H. Ahmed

doi:10.1097/01.elx.0000524702.08796.75

Q2 2017

Use of sofosbuvir in combination with ribavirin with or without pegylated interferon for the treatment of patients with hepatitis C infection genotype 4

Yehia M. Al Shazly · Sherif M. Mohamed · Ossama A. Ahmed · Rasha S. Mohamed · Ahmed H. Ahmed

10.1097/01.elx.0000524702.08796.75 389 المشاهدات 0 الاقتباسات

الاقتباسات

389

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Yehia, M. A. S., Sherif, M. M., Ossama, A. A., Rasha, S. M., Ahmed, H. A. (2017). Use of sofosbuvir in combination with ribavirin with or without pegylated interferon for the treatment of patients with hepatitis C infection genotype 4. Egyptian Liver Journal. https://doi.org/10.1097/01.elx.0000524702.08796.75

Gamal Shiha; Seham Seif; Maha Maher; Shahera Etreby; Waleed Samir; Khaled Zalata · 2014

استشهاد

389

Tissue microarray as a research tool to study non-neoplastic liver diseases

Mohamed H. Abdel-Rahman; Ahmad A. Agour; Dina S. El-Azab · 2014

استشهاد

388

Prevalence of hepatitis C virus seroconversion among hemodialysis patients in Egypt

Iman I. Sarhan; Cherry R. Kamel · 2015

استشهاد

391

Prevention of paracentesis-induced circulatory dysfunction